Quten absorbs NAD critique, plans partial appeal
This article was originally published in The Tan Sheet
Executive Summary
Quten Research Institute, the maker of Qunol CoQ10 supplements, will appeal a National Advertising Division recommendation that it discontinue claims about its liquid product's comparative absorbability. The Council of Better Business Bureaus unit, acting on a challenge by the Council for Responsible Nutrition, found the claim that Liquid Qunol has "Up to 6X better absorption than regular CoQ10" was derived solely from in vitro studies, but added evidence supports claims of 300 percent greater absorption in humans. While Quten said it will appeal NAD's finding on the 6X claim, the company accepts other points in NAD's Dec. 3 1report, which included discontinuing a potentially misleading claim that a CoQ10 ingredient "has been used in several clinical studies." The Novato, Calif., firm voluntarily discontinued a "Doctor Recommended" claim
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.